Cancer News and Research

Latest Cancer News and Research

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Oral MCP enhances anti-cancer, anti-metastatic effects of radiation therapy in prostate cancer treatment

Oral MCP enhances anti-cancer, anti-metastatic effects of radiation therapy in prostate cancer treatment

Botanical formula improves effect of tamoxifen drug in ER+ human breast cancer

Botanical formula improves effect of tamoxifen drug in ER+ human breast cancer

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

UTEP engineers developing technology that could help predict breast cancer risk

UTEP engineers developing technology that could help predict breast cancer risk

Nonprofit group launches website that provides education, information about breast density

Nonprofit group launches website that provides education, information about breast density

Tumor necrosis factor helps regulate sensitivity to bitter taste

Tumor necrosis factor helps regulate sensitivity to bitter taste

Unique approach to academia-industry training could help improve proton therapy treatment

Unique approach to academia-industry training could help improve proton therapy treatment

Scientists identify protein that could help tame severe inflammation

Scientists identify protein that could help tame severe inflammation

Researchers uncover methylated DNA markers that may lead to noninvasive cancer screening

Researchers uncover methylated DNA markers that may lead to noninvasive cancer screening

Men with prostate cancer benefit from BRCA-targeting drug

Men with prostate cancer benefit from BRCA-targeting drug

U of T studies find harmful vehicle emissions spreading farther than thought across Canadian cities

U of T studies find harmful vehicle emissions spreading farther than thought across Canadian cities

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Astellas, Potenza collaborate to develop immuno-oncology therapeutics for patients with certain cancers

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

Cardio3 BioSciences reports absence of short term adverse events in first patient following NKG2D CAR T-cell infusion

Cardio3 BioSciences reports absence of short term adverse events in first patient following NKG2D CAR T-cell infusion

Novel genetic datashare initiative launched to improve detection of inherited breast and ovarian cancers

Novel genetic datashare initiative launched to improve detection of inherited breast and ovarian cancers

Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

Blue Cross Blue Shield of Michigan, UMHS collaborate to improve quality of care for Michiganians

Data presented at AACR 2015 recognizes value of EKF PointMan technology for assessing lung cancer mutation status

Data presented at AACR 2015 recognizes value of EKF PointMan technology for assessing lung cancer mutation status

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Study confirms that coffee inhibits growth of tumours, reduces risk of breast cancer recurrence

Study confirms that coffee inhibits growth of tumours, reduces risk of breast cancer recurrence

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.